PROTAGONIST THERAPEUTICS INC - COM

Historical Holders from Q2 2022 to Q3 2025

Type / Class
Equity / COM
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
60,616
Holdings value
$4,026,721
% of all portfolios
0%
Number of holders
1
Number of sells
-1
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of PROTAGONIST THERAPEUTICS INC - COM

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 60,616 $4,026,721 -$46,368 $66.43 1
2025 Q2 61,314 $3,388,825 -$7,793 $55.27 1
2025 Q1 61,455 $2,971,964 -$3,434 $48.36 1
2024 Q4 61,526 $2,374,904 -$14,243 $38.60 1
2024 Q3 61,895 $2,785,275 -$24,480 $45.00 1
2024 Q2 62,439 $2,163,511 -$13,167 $34.65 1
2024 Q1 62,819 $1,817,354 -$3,529 $28.93 1
2023 Q4 62,941 $1,443,237 -$3,394 $22.93 1
2023 Q3 63,089 $1,052,325 -$534 $16.68 1
2023 Q2 63,121 $1,743,402 $27.62 1
2023 Q1 63,121 $1,451,783 $23.00 1
2022 Q4 63,121 $688,650 -$739,261 $10.91 1
2022 Q3 130,881 $1,103,000 -$241,962 $8.43 1
2022 Q2 159,592 $1,324,000 +$1,324,000 $8.30 1